Clinical Trial Update: A Multi-country, Cross-sectional Quantitative Study Exploring Awareness, Understanding, and Perceptions of the Relation Between Cardiorenal Metabolic Conditions and MASLD/MASH Among Healthcare Providers, People With MASLD/MASH, and At-risk Population

View source ↗

Summary

A completed multi-country cross-sectional study assessing awareness, understanding, and perceptions of the relationship between cardiorenal metabolic conditions…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatohepatitis
• Metabolic Dysfunction-associated Steatotic Liver Disease

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Metabolic Dysfunction-associated Steatohepatitis (MASH) | Status: COMPLETED